Category: Frequent Updates

Medtronic, Zydus Hospitals to facilitate remote stroke care using AI

Medtronic, Zydus Hospitals to facilitate remote stroke care using AI

Healthcare IT news

Zydus Hospitals in Ahmedabad and Medtronic India have tied up to launch an AI-enabled hub-and-spoke network to support stroke patients in the western coastal state of Gujarat. An initiative of the pharmaceutical giant Zydus Group, the multispecialty hospital chain has locations across Gujarat and Uttar Pradesh. Its Ahmedabad branch runs two hospitals – a super speciality centre and a primary hospital – with over 660 beds.
HOW IT WORKS
According to a press release, Zydus and Medtronic will leverage locally developed AI technologies to deliver timely diagnosis and treatment to stroke patients living in rural communities. With an AI capability, a team of stroke…

Continue Reading
VinBrain harnesses Stanford data to improve radiology AI

VinBrain harnesses Stanford data to improve radiology AI

MobiHealthNews

Vietnamese healthcare AI developer VinBrain has started a new partnership with Stanford University to enhance AI medical imaging.Based on their latest data use agreement, Stanford will initially provide VinBrain access to about 240,000 anonymised medical images and reports to train and test the AI on its DrAid clinical decision support platform while also helping improve the accuracy of an information extracting method for structuring radiology reports called RadGraph.
WHY IT MATTERS
According to VinBrain, its latest partnership with Stanford aims to enhance efficiency in radiology reports while “tackling complexity, ambiguity, and limitations in medical image interpretation.”
Through Stanford’s support, the company will be able…

Continue Reading
Roundup: First insomnia DTx in South Korea gets regulatory nod and more briefs

Roundup: First insomnia DTx in South Korea gets regulatory nod and more briefs

MobiHealthNews

South Korea clears first local insomnia DTx The South Korean Ministry of Food and Drug Safety has given its first market approval for a digital therapeutic device for treating insomnia, according to a news report.
The mobile-based medical device-as-a-software called Somzz by Aimmed delivers a CBT programme that helps increase sleep duration.
India OKs health monitoring smartwatch CardiacSense
Xplore Health, a medical tech company in India, has received approval from the Indian Regulatory Authority for a wearable health monitoring device it carries.
The company is the distributor of the medical smartwatch product of Israeli medical device developer CardiacSense.
Based on a news report, the smartwatch enables continuous monitoring of vital…

Continue Reading
Is Interoperability Tech Worth the Investment? Experts Say Yes for 3 Reasons

Is Interoperability Tech Worth the Investment? Experts Say Yes for 3 Reasons

MedCity News

Editor’s note: This story is based on discussions at Abarca Forward, a conference in San Juan, Puerto Rico, hosted by Abarca, a pharmacy benefit manager. MedCity News’ Editor-in-Chief Arundhati Parmar and Senior Reporter Katie Adams were invited to attend and speak at the conference. All travel and related expenses for the team were covered by Abarca. However, company officials had no input in editorial coverage. 
In order for the U.S. healthcare system to operate smoothly, various stakeholders must cooperate with one another and share data seamlessly. But this notion is far from being achieved — the industry is still seriously plagued by…

Continue Reading
How to Rein in Unpredictability During High-Traffic Respiratory Illness Season

How to Rein in Unpredictability During High-Traffic Respiratory Illness Season

MedCity News

‘Tripledemic’ concerns have been on the rise with the collision of flu, Covid-19, and respiratory syncytial virus (RSV) wreaking havoc in clinics and hospitals. Yet staff are expected to provide smooth, fast, and effective care journeys for all, no matter the volume of patients. We know, however, that everything doesn’t always go as planned when patient traffic explodes. Bottlenecks like long wait times and limited appointment options inevitably skyrocket, and staff bear the brunt of patients who (understandably) want to be seen immediately, in conjunction with staff members intermittently being out sick themselves.
Living in an environment of extreme health unpredictability affects…

Continue Reading
Moderna Flu Vax Prompts Response to More Common Strains, But Misses in Influenza B

Moderna Flu Vax Prompts Response to More Common Strains, But Misses in Influenza B

MedCity News

A Moderna messenger RNA vaccine for influenza now has preliminary data from a pivotal study showing the shot prompted a strong immune response to the more common strains of the virus but fell short against less common strains.
The results reported Thursday are from one of two pivotal studies for the Moderna vaccine, mRNA-1010, which is assessing the shot for safety and immune response. A separate Phase 3 study is evaluating the shot for efficacy. Results from that study could come as early as next month. Moderna’s vaccine encodes hemagglutinin, a protein on the surface of the influenza virus that is also…

Continue Reading
Talkspace Launches New Mental Health Portal for Employers

Talkspace Launches New Mental Health Portal for Employers

MedCity News

Virtual behavioral health provider Talkspace unveiled a new product Thursday that provides employers with access to a library of mental health resources that they can share with employees.
New York City-based Talkspace serves employers, payers and consumers, and provides self-guided mental health programs, therapy and psychiatry. Its new product, Talkspace Engage, aims to help employers promote their mental health benefits to their employees, a challenge that many companies struggle with, said Erin Boyd, chief growth officer of enterprise at Talkspace. “One resounding common theme that we heard among [employers] was that, ‘I don’t know how to get people to use these benefits…

Continue Reading
‘A Mindset Shift’: How Senior Care Communities Adapt to Modern Tech Expectations

‘A Mindset Shift’: How Senior Care Communities Adapt to Modern Tech Expectations

HealthTech Magazine

Glen Tibbitts, United Church Homes’ Corporate Director of IT and HIPAA Security Officer, says he’s noticed a “mindset shift” as residents’ expectations change. Photography by Leonardo Carrizo
“Otherwise, you’ll see people with a device that’s still in the box,” he says. “People will tend to engage with technology if they feel they have agency in the process. That’s really important.”
Looking ahead, UCH is piloting a number of clinical and lifestyle technologies, including a smart badge that transcribes the speech of employees and family members for deaf patients.
“It’s all about abundant life and abundant aging,” Tibbitts says. “We want to make the move…

Continue Reading
Health Transformation Alliance Teams up With Cognoa for Autism Diagnostic Device

Health Transformation Alliance Teams up With Cognoa for Autism Diagnostic Device

MedCity News

The Health Transformation Alliance (HTA), a group of nearly 60 large employers, announced Thursday it is partnering with pediatric behavioral health company Cognoa for its diagnostic device for autism.
HTA is a cooperative of self-insured employers, including Walgreens, CocaCola, Verizon and American Express. Palo Alto, California-based Cognoa, meanwhile, is a developer of AI-based technologies for early diagnosis of children with developmental and behavioral health conditions. Its Canvas Dx product is authorized by the Food and Drug Administration and assists healthcare providers in diagnosing autism spectrum disorder for children ages 18 months through 72 months. The product is the first of its sort…

Continue Reading
Cell Therapy Biotech Talaris Ends Two Kidney Transplant Trials, Restructures

Cell Therapy Biotech Talaris Ends Two Kidney Transplant Trials, Restructures

MedCity News

Talaris Therapeutics aimed to transform solid organ transplants with a cell therapy that replaces anti-rejection drugs patients need for the rest of their lives. But after clinical trial setbacks, the biotech has decided to end two kidney transplant studies. Although a separate test of its experimental therapy is continuing in a rare autoimmune condition, Talaris has commenced a restructuring plan that it said could culminate in a merger or sale of the company.
The restructuring announced Thursday will lead to the layoff of about one-third of Talaris’s staff. As of the end of the third quarter of 2022, the Louisville, Kentucky-based biotech…

Continue Reading